Saturday, January 31, 2026
22.2 C
Bengaluru

Decoding Indian Pharma’s Approach to Digital Adoption and Transformation in a COVID-19 Constrained World

First Ever India Centric Survey: A CredoWeb – MedicinMan Research Project

The current challenges faced by Indian Pharma:
  • Sales are declining in most cases. However, the sales of established brands are steadily growing, even with the field force unable to meet doctors at pre-COVID levels.
  • Most non-COVID patients are unable to access doctors due to various constraints, forcing doctors to quickly adopt digital in some form.
  • Healthcare is at an inflection point, where digital adoption has become a necessity to fix its inefficient and already broken model of decreasing interest by physicians to meet Medical Reps, poor quality and high attrition of field force, legacy systems and lack of customer engagement and experience oriented marketing.

Solutions: The current pandemic may continue for an uncertain period of time – estimates from 12 to 24 months – by which time certain fundamental behavior change would have been cemented, with regards to consumers adopting technology as has already happened with other areas, be it banking, transportation and other conveniences (Ola, Dunzo, Swiggy, Amazon, PayTM, Swiggy and a plethora of consumer services).

Indian Pharma will need to adapt business practices to deliver treatments and services for patients by increasing investment in digital technologies and supply chain management.

Keeping these challenges in mind, MedicinMan in partnership with CredoWeb, set up the Digital Excellence Pharma Academy (DEPA), as a knowledge sharing platform with thought leaders from Indian and global pharma to share experiences, insights and case studies.

As a part of DEPA, we also initiated a research project with a detailed survey to understand the current status and issues faced by Indian Pharma companies in adopting digital to bridge the pharma – physicians disconnect.

You can know more about the scope and scale of this research project and survey at  https://anupsoans.typeform.com/to/T3ccrxlF

The Change (Digital) Adoption Curve from COVID-19 Crisis to Digital Transformation

To watch the first discussion on the Digital Excellence Pharma Academy research project that aims to understand the Indian Pharma people’s perspective, register for today’s webinar on – https://www.credoweb.in/discussion/560/decoding-indian-pharmas-approach-to-digital-adoption-and-transformation-in-a-covid-19-world

In this session by Deep Bhandari, we share the preview of the research project.

Hot this week

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead

The latest PharmaTrac report for December 2025 offers a...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Topics

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Zydus vs. Helsinn — What It Really Means for Indian Pharma

On December 24, 2025, the Delhi High Court delivered...

Worldclass Healthcare But Out of Reach for Most Indians?

When an eminent cardiologist like Dr. Sunil Chandy—former Director...

Managed Healthcare – Better Choice for India?

Managed care shifts healthcare from fragmented fee-for-service models to...
spot_img

Related Articles

spot_imgspot_img